| Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients (NCT02576093) | Dr. August Wolff GmbH & Co. KG Arzneimittel | 2014-03-01 |
| Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema) (NCT02001181) | Pfizer | 2013-12-01 |
| Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis (NCT01691209) | Bayer | 2013-10-01 |
| Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis (NCT01948869) | Bayer | 2013-10-01 |
| A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis (NCT01945086) | Janssen Pharmaceutical K.K. | 2013-09-01 |
| Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians (NCT01920464) | GlaxoSmithKline | 2013-04-01 |
| The Effect of Bathing and Moisturizers on Skin Hydration in Atopic Dermatitis: an in Vivo Study (NCT02028546) | Srinakharinwirot University | 2013-01-01 |
| Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study (NCT01737710) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-10-01 |
| Effects of Treatments on Atopic Dermatitis (NCT01631617) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2012-09-18 |
| Investigation of Topical SB705498 on Healthy Volunteers (NCT01673529) | GlaxoSmithKline | 2012-07-17 |
| Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis (NCT01652885) | Pfizer | 2012-07-01 |
| Systemic Therapies for Pediatric Atopic Dermatitis (NCT01447381) | Rady Children's Hospital, San Diego | 2011-10-01 |
| A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis (NCT01497119) | Janssen Pharmaceutical K.K. | 2011-10-01 |
| Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis (NCT01301508) | Pfizer | 2011-05-01 |
| A Study Assessing GW870086's Potential to Cause Skin Thinning (NCT01381445) | GlaxoSmithKline | 2011-04-14 |
| Effect of Dietary Phospholipids on Atopic Dermatitis (NCT01326520) | University of Jena | 2011-03-01 |
| A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo (NCT01299610) | GlaxoSmithKline | 2010-12-01 |
| Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis (NCT01011621) | Mantecorp Industria Quimica e Farmaceutica Ltd. | 2010-02-01 |
| Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children (NCT01772056) | Elena Rubio Gomis | 2009-12-01 |
| Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application (NCT01063218) | Galderma Brasil Ltda. | 2009-12-01 |
| Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream (NCT01098734) | Welichem Biotech Inc. | 2009-11-01 |
| Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4) (NCT00671528) | Organon and Co | 2009-07-01 |
| Effect of Moisturising Creams on Skin Moisture in Atopic Dermatitis (NCT00846235) | Orion Corporation, Orion Pharma | 2008-12-01 |
| Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis (NCT00673725) | Astellas Pharma Europe B.V. | 2008-03-01 |
| Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis (NCT00837551) | Welichem Biotech Inc. | 2008-03-01 |
| An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis (NCT01782729) | Janssen-Cilag Ltd.,Thailand | 2008-03-01 |
| Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels (NCT00616096) | University of Luebeck | 2008-01-01 |
| An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis (NCT01828879) | Janssen-Cilag Ltd.,Thailand | 2007-11-01 |
| A Long-Term Examination of Asthma From Childhood Through Adolescence (NCT00541255) | Isle of Wight NHS Trust | 2007-09-01 |
| Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis (NCT00354510) | GlaxoSmithKline | 2006-03-01 |
| Immunopharmacological Effects of Rituximab in Atopic Dermatitis (NCT00267826) | University of Bern | 2005-12-01 |
| Study Of Atopic Dermatitis In Pediatrics (NCT00257569) | GlaxoSmithKline | 2005-08-01 |
| Study Of Single And Ten Day Repeat Atopical Applications Of GW842470X Cream On The Skin Of Patients With Atopic Dermatitis (NCT00356642) | GlaxoSmithKline | 2005-06-10 |
| Efalizumab for Moderate to Severe Atopic Dermatitis (NCT00226057) | Oregon Health and Science University | 2005-06-01 |
| Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis (NCT00121381) | Novartis | 2005-05-01 |
| Risk of Asthma in Infants With Atopic Dermatitis (NCT00459576) | Indiana University | 2005-05-01 |
| Efalizumab for Eczema (NCT00146003) | University of Medicine and Dentistry of New Jersey | 2005-03-01 |
| Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis (NCT00185510) | LEO Pharma | 2005-03-01 |
| A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis (NCT00106496) | Astellas Pharma Inc | 2004-10-01 |
| Histamine Pharmacogenetics in Children With Atopic Dermatitis (NCT00277433) | Virginia Commonwealth University | 2004-06-01 |
| Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment (NCT00480896) | Astellas Pharma Inc | 2004-06-01 |
| Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment (NCT00480610) | Astellas Pharma Inc | 2004-04-01 |
| Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders (NCT00189917) | Bavarian Nordic | 2004-04-01 |
| Protopic Ointment in Children Atopic Eczema (NCT00689832) | Astellas Pharma Inc | 2004-02-01 |
| Protopic Ointment in Adult Atopic Eczema of the Face (NCT00690105) | Astellas Pharma Inc | 2004-02-01 |
| Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients (NCT00523952) | Astellas Pharma Inc | 2004-01-01 |
| Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic (NCT00159523) | Norwegian University of Science and Technology | 2003-12-01 |
| Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis (NCT00691262) | Astellas Pharma Inc | 2003-10-01 |
| Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis (NCT00560326) | Astellas Pharma Inc | 2003-06-01 |
| Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis (NCT00535691) | Astellas Pharma Inc | 2003-04-01 |
| Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) (NCT00817076) | Organon and Co | 2003-03-01 |
| Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis (NCT00667160) | Astellas Pharma Inc | 2002-12-01 |
| Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis (NCT00666159) | Astellas Pharma Inc | 2002-12-01 |
| Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis (NCT00691145) | Astellas Pharma Inc | 2002-10-01 |
| Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) (NCT00152464) | UCB Pharma SA | 2002-03-20 |
| WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients (NCT02182570) | Boehringer Ingelheim | 2001-06-01 |
| WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients (NCT02182557) | Boehringer Ingelheim | 2001-06-01 |
| Distribution of Tacrolimus in Skin, Atopic Dermatitis (NCT00534508) | Astellas Pharma Inc | 2000-12-01 |
| Long-term Safety of Protopic in Atopic Eczema (NCT00560378) | Astellas Pharma Inc | 1998-06-01 |